Use cautionDrug recall · FDA · Published September 11, 2014
Qualitest Recalls Methylprednisolone Tablets Due to Subpotency
Qualitest Pharmaceuticals recalls specific lots of Methylprednisolone Tablets USP 4 mg because they may be subpotent at the 6-month stability time point.
📍Recalling firmQualitest Pharmaceuticals120 Vintage Dr NE · Huntsville, AL 35811-8216
✎ GovInfoNow plain-language explainer
Qualitest Pharmaceuticals is recalling specific lots of Methylprednisolone Tablets, USP 4 mg, because testing indicates they may be subpotent. This issue was identified during a 6-month stability time point evaluation. The recall affects both 100-count bottles and 21-count blister packs distributed nationwide. Read more at govinfonow.com/recall/45762-qualitest-pharmaceuticals-recalls-methylprednisolone-tablets-usp-4-mg-a-100.
“Qualitest Recalls Methylprednisolone Tablets Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45762-qualitest-pharmaceuticals-recalls-methylprednisolone-tablets-usp-4-mg-a-100. Based on FDA recall #D-1605-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1605-2014%22&limit=1).
Qualitest Pharmaceuticals voluntarily recalled Methylprednisolone Tablets USP 4 mg due to subpotency issues, the Food and Drug Administration said on Sept. 11, 2014. The Class III recall affects 159,913 tablets distributed nationwide.
How to tell if you have it
Brand: Qualitest Pharmaceuticals
Product: Methylprednisolone Tablets USP 4 mg
NDC 0603-4593-21 (100 count bottles), Lot T147F13A, Exp. 05/2015
NDC 0603-4593-15 (21 count blister pack), Lot S003M14, Exp. 05/2015
The hazard
The tablets are subpotent at the six-month stability time point, according to the FDA recall record.
Context
GovInfoNow's records show Qualitest Pharmaceuticals has 12 other recalls on file since April 19, 2013. Other recent recalls of similar products include Allopurinol Tablets Recall (July 20, 2015), Hydroxyzine Tablets Recall (June 29, 2015), and Disulfiram 500mg Tablets Recall (June 18, 2015). Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), Specialty Process Labs Thyroid Product Recall (Jan. 16, 2026), and Unichem busPIRone 5mg Tablets Recall (April 13, 2026) also involved subpotent drug risks.
How to tell if you have this one
Check your medication for the following details: Brand: Qualitest Pharmaceuticals. Product: Methylprednisolone Tablets, USP 4 mg. NDC/Package Types: 100 count bottles (NDC 0603-4593-21) or 21 count blister packs (NDC 0603-4593-15). Lot Numbers: T147F13A (Exp. 05/2015) for bottles, S003M14 (Exp. 05/2015) for blister packs.
Brand
Qualitest Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Contact Your Pharmacist
Reach out to your pharmacy or healthcare provider immediately to discuss the recall and determine if you have affected lots.
Verify Lot Numbers
Check the lot numbers on your packaging against the recalled lots T147F13A and S003M14 to confirm if your medication is included in this recall.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1605-2014 (September 11, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1605-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.